Vigabatrin/CPP-109 Patent was Granted by European Patent Office

Vigabatrin/CPP-109 Patent was Granted by European Patent Office

posted in: Emailwire.com Stock News by On July 9th, 2010

(EMAILWIRE.COM, July 09, 2010 ) Cheyenne, WY – Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) shares surged 66% to trade at 1.47 after the company announced that the European Patent Office granted to Brookhaven Science Associates/Brookhaven National Laboratory (Brookhaven) a European patent…
Original post here Email Wire Press Releases

For hot penny stock picks, daily small cap alerts, and stock market news alerts visit http://www.stockorange.com

Comments are closed.